We were able to detect both G12C & G12V and G12F mutants in publicly available datasets at comparable frequencies to our study (Table 1)26–28, indicating that the KRAS G12C mutation co-occurrence is a consistent finding across lung cancer studies and patient populations. The gene discussed is KRAS; the disease is lung carcinoma.